The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder

Authors: Matthew L. Banks, Jon E. Sprague

This article argues that the dopamine 3 receptor could serve as a biomarker for opioid use disorder.

External Link

https://onlinelibrary.wiley.com/doi/10.1111/adb.13369

Materials

Adobe PDF The dopamine 3 receptor as a candidate biomarker andtherapeutic for opioid use disorder

Related Topics

Research
Treatment

Contact Us

The International Consortium of Universities for Drug Demand Reduction (ICUDDR) supports the rapid improvement in competencies and skills among current and future generations of addiction professionals to meet the increasing demand for prevention, treatment and public health services. Toward this end, the ICUDDR facilitates networking among universities to promote high quality education and training in the field of addiction prevention, treatment and public health interventions. It also pursues related applied addictions research, outreach and advocacy.

ICUDDR is funded by the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe at home by countering international crime, illegal drugs, and instability abroad. INL helps countries deliver justice and fairness by strengthening their police, courts, and corrections systems. These efforts reduce the amount of crime and illegal drugs reaching U.S. shores.

Translations (via Google Translate):